Articles / Innovation
RNOH ranked UK’s leading orthopaedic hospital in Newsweek specialised hospital poll
Published on: 6 December 2023
A 10-year study on functional outcomes after cancer surgeries won a top award at the Global Connective Tissue Oncology Conference (CTOS) 2023 Global Conference award. The study, led by RNOH clinicians Dr Sherron Furtado & Mr Craig Gerrand, won in the Outstanding Poster Presentation Award in the Orthopaedic and Reconstructive Surgery Category. The CTOS is one of the largest connective tissue oncology conferences held in the world and took place in Dublin last month.
STanmore OutcoMes Project (STOMP) is a large strategic 10-year platform study set up in the London Sarcoma Service, which captures holistic personalised functional and quality of life outcomes after complex orthopaedic surgeries for musculoskeletal tumours.
At CTOS, Dr Sherron Furtado presented findings from the first year of this study, which recruited close to 100 patients. In the next decade, the team aims to recruit 1000 people to form the largest database globally. This will be significant in informing evidence-based clinical practice, providing better information for shared decision-making, patient management and rehabilitation care delivery.
We extend our special thanks to the funders of STOMP: the RNOH Charity and the Team comprising of key people including Teja Joshi, Deborah Eastwood, Craig Gerrand and Sherron Furtado, RNOH Clinical staff, MSc students from UCL who attended this global congress, and the PhD students from Imperial College London supervised by Dr Furtado and Mr Gerrand.